-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Karuna Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2018 to 2023.
- Karuna Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$101M, a 102% decline year-over-year.
- Karuna Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$386M, a 69.2% decline from 2022.
- Karuna Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$228M, a 126% decline from 2021.
- Karuna Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$101M, a 44.4% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)